Plectin is one of the largest and most versatile cytolinker proteins known. In basal keratinocytes it links the intermediate ®lament network to cell membrane-associated hemidesmosomes. Several mutations in its gene have been identi®ed that lead to the recessive disease epidermolysis bullosa with muscular dystrophy. We report here a mutation that leads to a dominant form of the disease, epidermolysis bullosa simplex Ogna. We found that the epidermolysis bullosa simplex Ogna phenotype is due to a site-speci®c missense mutation within plectin's rod domain. Further, we show that epidermolysis bullosa simplex Ogna is not restricted to a single Norwegian kindred as previously believed. A German family with the phenotypic hallmarks of epidermolysis bullosa simplex Ogna was found to carry an identical de novo mutation. These two mutations arose about 200 y apart in time. Consistent with the absence of muscular symptoms in these patients, muscle biopsies from several epidermolysis bullosa simplex Ogna members of the Norwegian kindred showed normal staining patterns using antibodies to plectin. Skin changes in epidermolysis bullosa simplex Ogna patients are documented on the ultrastructural level. Key words: cytokeratins/cytolinkers/missense mutations/plakins/PLEC1 gene. J Invest Dermatol 118: 87±93, 2002 E pidermolysis bullosa simplex (EBS) is a group of dominantly inherited intraepidermally blistering skin disorders. A new type of EBS was identi®ed in 1970 because of its generalized skin fragility (Gedde-Dahl, 1971 ). This Ogna type (EBS-O, OMIM 131950) is genetically linked to the GPT isozyme polymorphism (Olaisen and Gedde-Dahl, 1973) , which is assigned to chromosome 8q24 (Astrin et al, 1982; Pocha et al, 1988) . The other EBS types are known to be caused by mutations in the genes for the basal cell keratins 5 and 14, residing in the keratin clusters II and I on chromosomes 12 and 17 (Coulombe et al, 1991; Lane et al, 1992; Fuchs, 1999) . Defects in proteins other than keratins have only recently been found to cause certain types of EBS (see below).
Hemidesmosomes (HD) are junctional attachment complexes mediating adhesion of the basal keratinocytes to the underlying basal lamina (Borradori and Sonnenberg, 1999) . Ultrastructurally, HD consist of an intracellular attachment plate on the cytoplasmic face of the plasma membrane and an extracellular subbasal dense plate in the upper space of the lamina rara (lamina lucida), traversed by ®ne anchoring ®laments, together forming highly speci®c attachment devices that link basal cells and their cytoskeleton to the basal lamina (Anton-Lamprecht, 1992) . HD comprise various intracellular, transmembranous, and extracellular proteins: bullous pemphigoid antigen 1 and plectin are intracellular plaque proteins, a6b4 integrin and bullous pemphigoid antigen 2 are transmembranous with variably large extracellular collagenous domains, and laminin-5 is entirely extracellular and located in the deep lamina rara (Burgeson and Christiano, 1997) .
Plectin, one of the plakin/cytolinker protein family members (Ruhrberg and Watt, 1997; Wiche, 1998) , acts as a general crosslinking element of intermediate ®laments (Wiche et al, 1982; Wiche, 1998) . In epidermal cells it links keratins to the intracellular parts of desmosomes and HD (Wiche et al, 1983; Andra È et al, 1997; Rezniczek et al, 1998) . Plectin also binds desmin to the Z-line structures and dense plaques of striated and smooth muscle cells (Wiche et al, 1983; Reipert et al, 1999) . The cytokeratin binding site of plectin is contained in a sequence of~50 amino acids within the ®fth carboxy-terminal globular repeat (Nikolic et al, 1996) . The C-terminal domain interacts also with the long intracellular domain of the transmembranous integrin subunit protein b4 and integrin b4 binding occurs also via the N-terminal domain of the molecule (Rezniczek et al, 1998; Geerts et al, 1999) . In addition, plectin binds to actin and micro®laments (Seifert et al, 1992; Andra È et al, 1998) .
Plectin was ®rst cloned and sequenced from rat and later from man (Liu et al, 1996; McLean et al, 1996) and mouse . The human gene (PLEC1) was mapped to chromosome band 8q24 by in situ hybridization and was found to comprise 32 coding exons extending over 32 kb (Liu et al, 1996) . A number of additional ®rst coding exons, with alternative splicing into a common exon 2, were identi®ed in rat (Elliott et al, 1997) and mouse . Plectin also exists in a rodless form where exon 31 is skipped by splicing (Elliott et al, 1997) . Lack of plectin has been shown to result in the recessive human disease epidermolysis bullosa with muscular dystrophy (EB-MD) Gache et al, 1996; McLean et al, 1996; Pulkkinen et al, 1996; Smith et al, 1996; Uitto et al, 1996; Mellerio et al, 1997; Dang et al, 1998; Takizawa et al, 1999; Shimizu et al, 1999; Kunz et al, 2000; Rouan et al, 2000; Bauer et al, 2001) . The majority of EB-MD cases identi®ed to date are caused by frameshift and premature termination codon mutations in the plectin rod domain.
In this study we report the identi®cation of the plectin mutation causing EBS-O in the Norwegian family. In addition, we report an unrelated German family (BED10) with a de novo mutation in the same position con®rming the causal signi®cance of the mutation for the Ogna type. We further report that the expression of the mutation in both the Norwegian and the German family is identical by immuno¯uorescence and ultrastructure.
MATERIALS AND METHODS
Family material The Norwegian EB25 family (Gedde-Dahl, 1971) had (by 1991) 121 affected members (Gedde-Dahl, 1991) , and the maximum lod score was +15.2 for the linkage between EBS-O (EBS1) and GPT (Gedde-Dahl, 1987) .
Genomic DNA from 13 individuals, representing 14 8q24 haplotypes independent in descent, were selected for plectin sequencing. Seven of these individuals were EBS-O affected members from distantly related sibships of family EB25. These seven persons were chosen to ensure differentiation of the EBS1*Ogna-carrying 8q24 haplotype they had in common, from their seven control haplotypes (see Fig 1) . The other six persons consist of two nonaffected Norwegians (representing four haplotypes), and four individuals of a Dutch family with EB-MD (representing only two haplotypes independent in descent).
Because of ultrastructural and clinical similarity with the Ogna phenotype a German three-generation family (BED10, with a de novo sporadic EBS case in the second generation and two affected children in the third generation) identi®ed in 1997 was included in DNA sequencing (BED10-1, -2, -4, -7, -8). Nine members of this family (Fig 2a) were sampled for DNA haplotyping. The ®rst affected member of this family and her parents were additionally typed for six``forensic'' microsatellite DNA markers (Olaisen and Stenersen, 1996) .
DNA sequencing Plectin sequences deposited in GenBank (accession numbers U63610, Z54367, X59601, U53204, and NM_000445) were used to design polymerase chain reaction (PCR) primers that will yield overlapping DNA fragments 4±600 bp long covering the sequence from the start of exon 2 to the end of exon 32 (Liu et al, 1996) , and skipping only the longest introns.
All PCR primers were designed with m13 tails in order to use m13 primers for sequencing. All forward primers (as de®ned from the 5¢ to 3¢ by the sequences in GenBank) had m13 universal attached whereas all reverse primers had m13 reverse attached. For most PCR products only the universal sequencing was performed but in some cases the complementary strand was sequenced as a control or con®rmation. The PCR products were puri®ed either using the QIA quick PCR Puri®cation Kit (Qiagen) or the PCR product pretreatment kit (USB) and subsequently sequenced using PRISM AmpliTaq FS Dye Primer Cycle Sequencing Kit (Perkin Elmer) and run on the ABI 377 automatic sequencer. Sequences were aligned and compared using Sequencher 3.1.1 from Gene Codes Corporation.
In order to test unrelated normal individuals for the mutation an ABI Prism SNaPshot ddNTP Primer Extension Kit from Applied Biosystems was used. This kit extends a primer one nucleotide by adding a single ddNTP to its 3¢ end. A primer has to be designed with its 3¢ end one base downstream of the mutation to be assayed. The test was performed according to the manufacturer's protocol and samples were subsequently run on an ABI PRISM 377 DNA Sequencer before they were analyzed.
There is a polymorphism 10 bases downstream from the Ogna mutation so we designed two primers in case the polymorphism should give rise to problems during the extension step. All samples were tested with both primers: PLESNP1, CTGGAGGCTGCGAGGCAG; PLESNP2, CTGGAGGCCGCGAGGCAG.
DNA haplotyping Dinucleotide short tandem repeats were examined using primer pairs taken from Genethon (Dib et al, 1996) and/or Genome Data Bank (http://gdbwww.gdb.org/) on an ABI 377 Perkin Elmer sequencer. The keratin II cluster was examined by using thē anking short tandem repeats D12S1635, D12S1618, and D12S1586, and the 8q24 haplotypes by the most telomeric marker (D8S373) on the genetic map (Murray, 1995) , depicted in Fig 2(a) .
Electron microscopy Skin samples were obtained from two patients of the Norwegian Ogna family,  see  Fig 1) , and from all three affected members of the German family, BED10-1, BED10-2, and BED10-4 (mother and two children; see Fig 2a) . Skin samples included early blisters and perilesional and intact skin taken from the volar left forearm and left third ®nger (EB25-192) or thumb (EB25-16), and from the back of right or left hand (BED10-1, -2, and -4), respectively. The samples were ®xed in toto at room temperature with 3% glutaraldehyde in 0.1 mol cacodylate buffer, pH 7.4, and mailed to Heidelberg, where they were further processed for electron microscopy including post®xation with osmic acid and embedding in epoxy resin (glycid ether 100, formerly Epon 812) as detailed elsewhere (Anton-Lamprecht, 1992) . Semithin sections, stained with methylene blue, were investigated by light microscopy; ultrathin sections, mounted on Formvar-coated hexagonal copper grids and treated with uranyl acetate and lead citrate, were investigated by electron microscopy (Philips EM 400). The evaluation of the ultrastructure of HD and the dermo-epidermal junction was based both on the examination of full-length ultrathin sections (about 100 basal cells per section or more) from at least two or three grids of at least two tissue blocks of each patient skin sample, and additionally on personal experience with more than 700 cases of EB patients investigated by electron microscopy in Heidelberg, and hundreds of non-EB cases studied over 25 y (controls for HD and ultrastructure of dermoepidermal junctions).
Immuno¯uorescence studies ± skin and muscle biopsies Skin samples from the forearm and the lower back of patient BED10-1 (Fig 2a) were transported to Oslo in sterile medium until freezeembedded after 48 h in OCT Tissue Tek 4583 (Miles, Indiana). Biopsies obtained from the ventral or lateral aspect of the quadriceps muscle of ®ve EBS-O members of the EB25 family, as speci®ed in Fig 1, and from four controls were processed and immunostained as described elsewhere (Koss-Harnes et al, 1997) . Brie¯y, the tissue sections (both skin and muscle) were incubated with six different monoclonal antibodies (MoAbs) to rat plectin (clones 7A8, 10F6, and 5B3 were IgG1, 6C6 was IgG2, and 5C10 IgM; all supernatant¯uids were diluted 1:2±1:10) for 1 h followed by indocarbocyanine (Cy-3)-labeled goat antimouse heavy and light chain IgG (1:1000) (Jackson ImmunoResearch Laboratories, West Grove, PA). The immunostained sections were examined blindly by two investigators (F.L.J. and D.K.H.) at 400Q magni®cation with ā uorescence microscope (model E800; Nikon, Tokyo, Japan).
RESULTS
Identi®cation of the mutation in the Norwegian EB25 pedigree Among the 14 chromosomes sequenced extensively over the exon 2 to exon 32 region only one base substitution was present heterozygous in all seven EBS-Ogna individuals, i.e., on the putative EBS-O haplotype. This C > T transition at genomic position 13775 (GenBank accession number U63610), corresponding to cDNA position 6328 (GenBank accession number Z54367; position 6049 in U53204) located in exon 31 (Liu et al, 1996) , was detected using ple50 primers (PLE50F, CGCAACACAAGGCTGACATC; PLE50R, TCCTCCACGT-TGGCTTTCAG) to amplify the DNA fragment and sequence the product. This mutation leads to a shift from CGG > TGG in codon 2110 (Liu et al, 1996 ; codon 2000 in U53204), resulting in the substitution of arginine with tryptophan (R2110W) in the plectin polypeptide. Most other base substitutions observed could be accounted for by normal polymorphisms (to be published elsewhere). As controls 103 clinically normal Norwegians were found to be homozygous for C at position 13775 (cDNA 6328). Fifty-two of the control individuals were examined by standard sequencing and 51 by SNaPshot sequencing (results not shown).
Identi®cation of the mutation in the German BED10 family When DNA samples from the BED10 family were examined with the ple50 primers, the three EBS-affected members also revealed heterozygosity for the identical C13775T mutation, whereas the normal grandparents lacked the mutation (Fig 2b) . Tests with six``forensic'' markers used in routine paternity testing on individuals 4, 7, and 8 con®rmed the family relationships.
The identi®cation of the same mutation in both families, and in one of them de novo, con®rms that this mutation is in fact the cause of the Ogna type of EBS.
Nine members of the German family BED10 (Fig 2a) were also DNA haplotyped with markers at the keratin cluster II and markers on 8q24. A keratin 5 mutation was ruled out by independent segregation. Both affected children, BED10-1 and BED10-2, had inherited the same maternal grandfather's 8q24 haplotype (Fig 2a) . The 8q24 haplotyping revealed that also the oldest sibling BED10-5 carries this paternal haplotype harbouring the mutation in the three affected individuals, but without having the clinical disease and also being 13775C homozygous as her father. Hence, BED10-4 at the same time is a de novo mutant for C13775T and for the dominant clinical disease (Fig 2b) .
Results of electron microscopy: diagnosis and pathomorphogenesis Early blisters and perilesional and intact skin of two Norwegian Ogna patients, EB25-16 and EB25-192, and of the three German EBS family BED10 members disclosed speci®c ultrastructural abnormalities that clearly distinguish this type of EBS from classical Ko Èbner cases (Anton-Lamprecht, 1992; Gedde-Dahl and Anton-Lamprecht, 1996) . This pathomorphogenetic pattern was ®rst observed in the skin samples of the two Norwegian Ogna cases. As the same pattern occurred similarly in all three German EBS patients, these ultrastructural criteria led to the diagnosis of EBS-O and prompted the proposal to include this family into the ongoing series of plectin haplotyping and mutational analysis in Oslo.
Blisters do not start via cytolysis of subnuclear central portions of the basal cell cytoplasm as in EBS Ko Èbner and EBS Weber± Cockayne (Haneke and Anton-Lamprecht, 1982; AntonLamprecht, 1992 ) but originate in the deepest areas of the basal cell cytoplasm, immediately above (but not within) HD. The resulting blister¯oor is covered by the basal lamina±anchoring ®brils complex and debris of basal cytoplasm including fragments of HD that become rapidly destroyed in early blisters. Old blisters may therefore appear as junctional EB (``pseudojunctional'' EBS). In unseparated perilesional and preblistering skin keratin ®laments are unconspicuous and normal for basal cells, but their insertion into the HD attachment plates is mostly impaired, irrespective of the site of biopsy. Clumped basal keratins as in the Dowling±Meara type (Anton-Lamprecht and Schnyder, 1982; Anton-Lamprecht, 1992 , 1994 were never found in any of the skin samples. The HD themselves are normally structured with regard to their extracellular portions and have well developed subbasal dense plates and anchoring ®laments in the lamina rara, but their intracellular attachment plates are mostly thin and frequently separated into small, triangular segments; their thickness is then about half of normal HD attachment plates. Some HD may appear normal with clear attachment and inner plates (Fig 3) . This speci®c ultrastructure is signi®cantly different from classical cases of EBS Ko Èbner, EBS Weber±Cockayne, and EBS Dowling± Meara, which all form entirely normal HD (Haneke and AntonLamprecht, 1982; Anton-Lamprecht, 1992 , 1994 . The aberrant ultrastructure of HD attachment plates and their frequent fragmentation pointed to one of the plaque proteins, either plectin or bullous pemphigoid antigen 1, as the primary target of the underlying dominant mutation.
Results of immuno¯uorescence studies As shown previously, skin samples from 10 affected members of the EBS-O family EB25, in contrast to nine controls, consistently lacked immunoreaction of the basal cell layer with two out of six MoAbs against rat plectin, thus distinguishing EBS-O from controls (Koss -Harnes et al, 1997) . The two abnormally reacting MoAbs, 10F6 and 5B3, are known to react with epitopes in the rod domain of the molecule (Foisner et al, 1994) . When skin samples from forearm and lower back of patient BED10-1 of the German family were examined using one of these antibodies (5B3), a lack of basal keratinocyte staining was observed, similar to the Norwegian cases (Fig 4a) .
As plectin de®ciency has serious consequences for muscle tissues, muscle samples from ®ve members of the EB25 kindred (speci®ed in Fig 1) and of four controls were investigated by immuno¯uor-escence microscopy using the six different MoAbs to rat plectin. No differences in the staining patterns of Ogna muscle versus normal muscle were found (Fig 4b) . Among the ®ve volunteer EBS-O patients, one (EB25-66) carried HLA-B27 and had the diagnosis of ankylosing spondylitis (Mb. Behkterev), and another (EB25-336) had a pronounced ®bromyalgia (Fig 1) . Neither of them showed aberrant plectin staining patterns of their muscles, however.
DISCUSSION
The relationship between clinical phenotype and genotype became the focus of interest when detection of speci®c mutations became available. Some clinical entities turned out to be caused by mutations at more than one gene locus, whereas others are caused by different mutations in one and the same gene. The lack of reports of further EBS-O families after its ®rst description 30 y ago (Gedde-Dahl, 1971 ) and its chromosomal regional assignment 15 y ago (Olaisen and Gedde-Dahl, 1973; Astrin et al, 1982; Pocha et al, 1988) might be better understood if only very few mutations, perhaps only the R2110W substitution, can cause this phenotype. There are similar examples in the keratin genes: EBS with mottled pigmentation, known from rare families, was found to be sitespeci®c for one and the same C to T mutation in codon 24 of the keratin 5 locus in two independent families (Uttam et al, 1996) as well as a de novo mutation in a third unrelated family (Irvine et al, 1997) . In plectin the substitution of arginine with tryptophan at codon 2110 might affect a comparably critical position causing this particular EBS-O phenotype.
It is dif®cult to understand the lack of immunostaining of the basal keratinocytes in dominant EBS-Ogna with antiplectin antibodies compared to normal staining of the suprabasal keratinocytes and of muscle tissues. Plectin is probably existing mainly as dimers (Foisner and Wiche, 1987) so that only a quarter of the molecules should have two normal peptides, but this does not explain absence of antigenicity. Antibody 5B3, which does not stain the basal layer in EBS-O, is known to bind to the rod domain (Foisner et al, 1994) . The exchange of tryptophan for arginine within the rod domain either may prevent dimer formation or may in¯uence the secondary folding of the polypeptide so that binding sites even in domains other than the rod are grossly disturbed. Plectin binding might be impaired either to the basal cell cytokeratin subunit proteins 5 and 14, or to the hemidesmosomal transmembrane protein integrin a6b4, both of which are known as direct interaction partners of plectin (Nikolic et al, 1996; Rezniczek et al, 1998; Steinbo Èck et al, 2000) . Binding sites for the integrin b4 subunit have been identi®ed in both the C-and N-terminal domains of plectin, and a major intermediate ®lament binding site has been mapped to the linker segment between repeat modules 5 and 6 in the C-terminal domain.
Previous studies have not ruled out, however, that plectin might have more than one binding site for intermediate ®laments such as cytokeratins. In fact it has been reported that a number of MoAbs to plectin with rod-based epitopes interfere with the in vitro interaction of plectin with vimentin and lamin B to different degrees (Foisner et al, 1991) .
Thus, if different binding sites exist for basal and for suprabasal keratins, only the K5/14 binding site may be affected and disturbed by the Ogna mutation. Another explanation for the differential staining patterns of some antibodies in different epidermal cell layers and in muscle could be that different oligomeric states of plectin, such as dimers versus monomers, are required for speci®c functions of plectin in different cells. Finally, it is equally likely that, due to misfolding of the protein, the mutation causes a gain of function, such as binding to a protein or structure that is normally not occurring. This may have harmful consequences in cell types such as basal keratinocytes, but not in others.
Recent studies on genotype±phenotype correlations on EBS (Sùrensen et al, 1999) , EB-MD , and EB dystrophica (Bruckner-Tuderman et al, 1999) demonstrate the complexity of these questions. Not only the position of the mutation but also the biochemical and functional nature of the amino acids affected by mutation and substitution contribute considerably to the resulting phenotypical expression and antigenicity. In conclusion, the invariable clinical expression of the mutation R2110W on 8q24 in all affected members of both Ogna families from Norway and Germany, the speci®c immunoreaction with lack of binding of antiplectin MoAb 5B3 to Ogna basal cells, and the identical speci®c ultrastructure of defective HD and mode of blister formation in both families underline that EBS-O is a nosologically distinct disease among EB and the ®rst dominant plectin disorder identi®ed.
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